The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Class III β-tubulin as a predictive marker for taxane-based first-line palliative chemotherapy in recurrent or metastatic gastric cancer.
Jun-Eul Hwang
No relevant relationships to disclose
Dae-Eun Kim
No relevant relationships to disclose
Hyun-Jeong Shim
No relevant relationships to disclose
Woo Kyun Bae
No relevant relationships to disclose
Sang-Hee Cho
No relevant relationships to disclose
Ik-Joo Chung
No relevant relationships to disclose